Skip to content

Drug interactions

Pegaspargase + Siponimod

Severity: Moderate

Pegaspargase and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pegaspargase is used with chemotherapy for leukemia and is associated with infections and hepatotoxicity, and siponimod lowers lymphocytes. Combined use may add to infection risk, and both can affect liver tests.

What this interaction means in plain words

Pegaspargase and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pegaspargase belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immune effects from asparaginase-related protein synthesis depletion and S1P-mediated lymphocyte sequestration.

What to do

Monitor infection signs and liver tests, and consider interrupting siponimod during intensive leukemia chemotherapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pegaspargase and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pegaspargase with Siponimod?

MediHelp rates the interaction as moderate. Pegaspargase and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pegaspargase is used with chemotherapy for leukemia and is associated with infections and hepatotoxicity, and siponimod lowers lymphocytes. Combined use may add to infection risk, and both can affect liver tests.

How serious is the interaction between Pegaspargase and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor infection signs and liver tests, and consider interrupting siponimod during intensive leukemia chemotherapy.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in